{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:55:45Z","timestamp":1740167745942,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40290-019-00275-2","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T12:03:27Z","timestamp":1553947407000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Danish Physicians\u2019 Views on the Appropriateness of the Involvement of Patients with Type 2 Diabetes in Regulatory Decision Making: A Qualitative Study"],"prefix":"10.1007","volume":"33","author":[{"given":"Mikkel Lindskov","family":"Sachs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Colding-J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Helboe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia K\u00e4lvemark","family":"Sporrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Fr\u00f8kjaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Jelic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-365X","authenticated-orcid":false,"given":"Susanne","family":"Kaae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"issue":"6","key":"275_CR1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jval.2016.04.006","volume":"19","author":"AC Muhlbacher","year":"2016","unstructured":"Muhlbacher AC, Juhnke C, Beyer AR, Garner S. Patient-focused benefit-risk analysis to inform regulatory decisions: the European Union perspective. Value Health. 2016;19(6):734\u201340.","journal-title":"Value Health."},{"issue":"5","key":"275_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/cts.12298","volume":"8","author":"JE Adamo","year":"2015","unstructured":"Adamo JE, Wilhelm EE, Steele SJ. Advancing a vision for regulatory science training. Clin Transl Sci. 2015;8(5):615\u20138.","journal-title":"Clin Transl Sci."},{"key":"275_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2147\/PPA.S104259","volume":"10","author":"JA Sacristan","year":"2016","unstructured":"Sacristan JA, Aguaron A, Avenda\u00f1o C, Garrido P, Carrion J, Gutierrez A, et al. Patient involvement in clinical research: why, when, and how. Patient Pref Adher. 2016;10:631.","journal-title":"Patient Pref Adher."},{"key":"275_CR4","first-page":"e32","volume":"4","author":"J Gallivan","year":"2012","unstructured":"Gallivan J, Kovacs Burns K, Bellows M, Eigenseher C. The many faces of patient engagement. J Participatory Med. 2012;4:e32.","journal-title":"J Participatory Med."},{"issue":"8","key":"275_CR5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/bmjqs-2015-004839","volume":"25","author":"J Ocloo","year":"2016","unstructured":"Ocloo J, Matthews R. From tokenism to empowerment: progressing patient and public involvement in healthcare improvement. BMJ Qual Saf. 2016;25(8):626\u201332.","journal-title":"BMJ Qual Saf."},{"issue":"10","key":"275_CR6","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","volume":"27","author":"G Elwyn","year":"2012","unstructured":"Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361\u20137.","journal-title":"J Gen Intern Med."},{"issue":"5","key":"275_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0277-9536(96)00221-3","volume":"44","author":"C Charles","year":"1997","unstructured":"Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681\u201392.","journal-title":"Soc Sci Med."},{"issue":"2","key":"275_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/135581969700200209","volume":"2","author":"A Coulter","year":"1997","unstructured":"Coulter A. Partnerships with patients: the pros and cons of shared clinical decision-making. J Health Serv Res Policy. 1997;2(2):112\u201321.","journal-title":"J Health Serv Res Policy."},{"issue":"4","key":"275_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/01944366908977225","volume":"35","author":"SR Arnstein","year":"1969","unstructured":"Arnstein SR. A ladder of citizen participation. J Am Inst Plann. 1969;35(4):216\u201324.","journal-title":"J Am Inst Plann."},{"issue":"2","key":"275_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.healthpol.2005.05.008","volume":"76","author":"JQ Tritter","year":"2006","unstructured":"Tritter JQ, McCallum A. The snakes and ladders of user involvement: moving beyond Arnstein. Health Policy. 2006;76(2):156\u201368.","journal-title":"Health Policy."},{"issue":"3","key":"275_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/asi.23202","volume":"66","author":"C Kelty","year":"2015","unstructured":"Kelty C, Panofsky A, Currie M, Crooks R, Erickson S, Garcia P, et al. Seven dimensions of contemporary participation disentangled. J Assoc Inf Sci Technol. 2015;66(3):474\u201388.","journal-title":"J Assoc Inf Sci Technol."},{"issue":"2","key":"275_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1017\/S1474746402000222","volume":"1","author":"P Beresford","year":"2002","unstructured":"Beresford P. User involvement in research and evaluation: liberation or regulation? Soc Policy Soc. 2002;1(2):95\u2013105.","journal-title":"Soc Policy Soc."},{"issue":"2","key":"275_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/0272989X09342277","volume":"30","author":"B Groot Koerkamp","year":"2010","unstructured":"Groot Koerkamp B, Weinstein MC, Stijnen T, Heijenbrok-Kal MH, Hunink MG. Uncertainty and patient heterogeneity in medical decision models. Med Decis Making. 2010;30(2):194\u2013205.","journal-title":"Med Decis Making."},{"issue":"8","key":"275_CR14","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1002\/art.11096","volume":"48","author":"TC Pouw Kraan van der","year":"2003","unstructured":"van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, et al. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum. 2003;48(8):2132\u201345.","journal-title":"Arthritis Rheum."},{"issue":"5","key":"275_CR15","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jaci.2012.03.026","volume":"129","author":"JM Drazen","year":"2012","unstructured":"Drazen JM. Asthma: the paradox of heterogeneity. J Allergy Clin Immunol. 2012;129(5):1200\u20131.","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"275_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40290-017-0200-z","volume":"31","author":"ML Sachs","year":"2017","unstructured":"Sachs ML, Sporrong SK, Colding-Jorgensen M, Frokjaer S, Helboe P, Jelic K, et al. Risk perceptions in diabetic patients who have experienced adverse events: implications for patient involvement in regulatory decisions. Pharm Med. 2017;31(4):245\u201355.","journal-title":"Pharm Med."},{"issue":"1","key":"275_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12529-013-9291-4","volume":"21","author":"E Shreck","year":"2014","unstructured":"Shreck E, Gonzalez JS, Cohen HW, Walker EA. Risk perception and self-management in urban, diverse adults with type 2 diabetes: the improving diabetes outcomes study. Int J Behav Med. 2014;21(1):88\u201398.","journal-title":"Int J Behav Med."},{"key":"275_CR18","volume-title":"Interviews: an introduction to qualitative research interviewing","author":"S Kvale","year":"1996","unstructured":"Kvale S. Interviews: an introduction to qualitative research interviewing. London: Sage Publications; 1996."},{"issue":"2","key":"275_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol."},{"issue":"4","key":"275_CR20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S1930297500005179","volume":"10","author":"WJW Botzen","year":"2015","unstructured":"Botzen WJW, Kunreuther H, Michel-Kerjan E. Divergence between individual perceptions and objective indicators of tail risks: evidence from floodplain residents in New York City. Judgm Decis Mak. 2015;10(4):365\u201385.","journal-title":"Judgm Decis Mak."},{"issue":"7","key":"275_CR21","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/risa.12157","volume":"34","author":"D Knuth","year":"2014","unstructured":"Knuth D, Kehl D, Hulse L, Schmidt S. Risk perception, experience, and objective risk: a cross-national study with European emergency survivors. Risk Anal. 2014;34(7):1286\u201398.","journal-title":"Risk Anal."},{"issue":"10","key":"275_CR22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/sj.jhh.1001596","volume":"17","author":"S Svensson","year":"2003","unstructured":"Svensson S, Kjellgren KI. Adverse events and patients\u2019 perceptions of antihypertensive drug effectiveness. J Hum Hypertens. 2003;17(10):671\u20135.","journal-title":"J Hum Hypertens."},{"issue":"4799","key":"275_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1126\/science.3563507","volume":"236","author":"P Slovic","year":"1987","unstructured":"Slovic P. Perception of risk. Science. 1987;236(4799):280\u20135.","journal-title":"Science"},{"key":"275_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF00143739","volume":"9","author":"B Fischhoff","year":"1978","unstructured":"Fischhoff B, Slovic P, Lichtenstein S, Read S, Combs B. How safe is safe enough? A psychometric study of attitudes towards technological risks and benefits. Policy Sci. 1978;9:127\u201352.","journal-title":"Policy Sci."},{"issue":"3","key":"275_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/0272-4332.213125","volume":"21","author":"M Bouyer","year":"2001","unstructured":"Bouyer M, Bagdassarian S, Chaabanne S, Mullet E. Personality correlates of risk perception. Risk Anal. 2001;21(3):457\u201365.","journal-title":"Risk Anal."},{"issue":"1","key":"275_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1539-6924.2006.00867.x","volume":"27","author":"B Chauvin","year":"2007","unstructured":"Chauvin B, Hermand D, Mullet E. Risk perception and personality facets. Risk Anal. 2007;27(1):171\u201385.","journal-title":"Risk Anal."},{"issue":"2","key":"275_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/713670162","volume":"2","author":"ML Finucane","year":"2000","unstructured":"Finucane ML, Slovic P, Mertz CK, Flynn J, Satterfield TA. Gender, race, and perceived risk: the \u2018white male\u2019 effect. Health Risk Society. 2000;2(2):159\u201372.","journal-title":"Health Risk Society."},{"issue":"3","key":"275_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1740-1461.2007.00097.x","volume":"4","author":"DM Kahan","year":"2007","unstructured":"Kahan DM, et al. Culture and identity-protective cognition: explaining the white male. J Empir Legal Stud. 2007;4(3):465\u2013505.","journal-title":"J Empir Legal Stud"},{"issue":"6","key":"275_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jval.2016.04.008","volume":"19","author":"FR Johnson","year":"2016","unstructured":"Johnson FR, Zhou M. Patient preferences in regulatory benefit-risk assessments: a US prspective. Value Health. 2016;19(6):741\u20135.","journal-title":"Value Health."},{"issue":"1","key":"275_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.0272-4332.2005.00580.x","volume":"25","author":"M Siegrist","year":"2005","unstructured":"Siegrist M, Keller C, Kiers HAL. A new look at the psychometric paradigm of perception of hazards. Risk Anal. 2005;25(1):211\u201322.","journal-title":"Risk Anal."},{"issue":"4","key":"275_CR31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/dme.13285","volume":"34","author":"T Rouyard","year":"2017","unstructured":"Rouyard T, Kent S, Baskerville R, Leal J, Gray A. Perceptions of risks for diabetes-related complications in type 2 diabetes populations: a systematic review. Diabet Med. 2017;34(4):467\u201377.","journal-title":"Diabet Med."},{"issue":"2","key":"275_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10389-016-0710-2","volume":"24","author":"MY Tawfik","year":"2016","unstructured":"Tawfik MY, Mohamed RA. The impact of communicating cardiovascular risk in type 2 diabetics on patient risk perception, diabetes self-care, glycosylated hemoglobin, and cardiovascular risk. J Public Health. 2016;24(2):153\u201364.","journal-title":"J Public Health."},{"issue":"10","key":"275_CR33","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.2337\/dc07-0499","volume":"30","author":"ES Huang","year":"2007","unstructured":"Huang ES, Brown SE, Ewigman BG, Foley EC, Meltzer DO. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care. 2007;30(10):2478\u201383.","journal-title":"Diabetes Care."},{"issue":"8","key":"275_CR34","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.socscimed.2011.02.033","volume":"72","author":"A Pilnick","year":"2011","unstructured":"Pilnick A, Dingwall R. On the remarkable persistence of asymmetry in doctor\/patient interaction: a critical review. Soc Sci Med. 2011;72(8):1374\u201382.","journal-title":"Soc Sci Med."},{"key":"275_CR35","unstructured":"EUPATI. Patient education! The A to Z of medicines development. 2018. https:\/\/www.eupati.eu\/ . Accessed 9 Mar 2018."},{"issue":"2","key":"275_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/09595230701829405","volume":"27","author":"J Bryant","year":"2008","unstructured":"Bryant J, Saxton M, Madden A, Bath N, Robinson S. Consumers\u2019 and providers\u2019 perspectives about consumer participation in drug treatment services: is there support to do more? What are the obstacles? Drug Alcohol Rev. 2008;27(2):138\u201344.","journal-title":"Drug Alcohol Rev."},{"issue":"3","key":"275_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0738-3991(93)90093-C","volume":"22","author":"SC Thompson","year":"1993","unstructured":"Thompson SC, Pitts JS, Schwankovsky L. Preferences for involvement in medical decision-making: situational and demographic influences. Patient Educ Couns. 1993;22(3):133\u201340.","journal-title":"Patient Educ Couns."},{"issue":"4","key":"275_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jcps.2011.01.001","volume":"21","author":"JM Leonhardt","year":"2011","unstructured":"Leonhardt JM, Keller LR, Pechmann C. Avoiding the risk of responsibility by seeking uncertainty: responsibility aversion and preference for indirect agency when choosing for others. J Consum Psychol. 2011;21(4):405\u201313.","journal-title":"J Consum Psychol."},{"issue":"6","key":"275_CR39","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jval.2016.03.1855","volume":"19","author":"AV Klein","year":"2016","unstructured":"Klein AV, Hardy S, Lim R, Marshall DA. Regulatory decision making in Canada: exploring new frontiers in patient involvement. Value Health. 2016;19(6):730\u20133.","journal-title":"Value Health."}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-019-00275-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40290-019-00275-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-019-00275-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T05:29:51Z","timestamp":1694755791000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40290-019-00275-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1007\/s40290-019-00275-2","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"type":"print","value":"1178-2595"},{"type":"electronic","value":"1179-1993"}],"subject":[],"published":{"date-parts":[[2019,3,30]]},"assertion":[{"value":"30 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Funding for this study was provided by Innovation Fund Denmark (Department of the Ministry of Higher Education and Science) and Novo Nordisk A\/S as part of a public-industrial co-funded Ph.D. project. Publication of the study results was not dependent on the approval of either funder.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mikkel Lindskov Sachs was employed as a full-time industrial Ph.D. student at the University of Copenhagen and Novo Nordisk A\/S during this study. Morten Colding-J\u00f8rgensen is a consultant and shareholder of Novo Nordisk A\/S. Katarina Jelic is a full-time employee and shareholder of Novo Nordisk A\/S. Per Helboe is a shareholder of multiple pharmaceutical companies, including Novo Nordisk A\/S. Sven Frokjaer, Sofia K\u00e4lvemark Sporrong, and Susanne Kaae have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study and the related data management were approved by the Data Management Unit of the Faculty of Health and Medicines, University of Copenhagen. The Danish Data Protection Agency approved the study (Reference: SUND-2016-47).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Participants were informed about the study and its aim and signed informed consent forms at the start of each interview. All participants were introduced to the purpose of the study. No financial incentives were offered or transacted. The confidentiality and anonymity of the data were ensured according\u00a0to national standards.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}